Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

OxySure Systems, Inc. (OXYS) Establishes Key Relationships At Medica 2013 Trade Fair

|Includes: OxySure Therapeutics, Inc. (OXYS)

OxySure® Systems announced earlier today an update from the Medica 2013 Trade Fair in Dusseldorf, Germany, the largest medical device trade show in world, with approximately 130,000 attendees per day over the four day trade fair. According to the press release issued, OxySure has experienced a high volume of inquiries regarding its proprietary respiratory solutions. In fact, several different countries have begun negotiations on distribution agreements to expand the OxySure brand and products.

"We are extremely pleased with the outcome of our presence at Medica 2013," stated Julian Ross, CEO of OxySure Systems. "There was a level of excitement from all the visitors to our booth and we have already begun negotiations with over a dozen countries regarding our groundbreaking oxygen from powder solutions. We feel confident that this will enable OxySure to continue expanding its presence on a truly global scale."

OxySure's flagship product, OxySure Model 615, introduces the first new oxygen technology in 50 years. There are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training, and the oxygen-generating technology is both safe and easy-to-use for the layperson. It can be placed virtually anywhere to help save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.

For more information, visit oxysure.com

QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.qualitystocks.net